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Summary 
The effect of patent activities on the business performance of firms in three different fields of 
industry was analyzed by exploring the relevant data via multilinear regressions. A research model 
was established based on previous studies and conceptual reasoning, followed by the construction of 
hypotheses to be verified. From the database of the USPTO (United States Patent and Trademark 
Office), 30 companies were selected in three different fields of industry (AI, Biotech, and Power 
plant) based on the number of patent applications filed spanning from 2013 to 2017 (near the top in 
each field). These fields were chosen as each of them show some distinctive features in their 
business operation. The business performance of these three clusters of companies was analyzed 
using the following variables: the rate of sales increase (per employee), profitability (per employee) 
and the ratio of R&D expenditure to sales (per employee), in relation to their patent activities. Linear 
regressions as well as multiple linear regressions (MLR) were performed where the effect of two-
way interaction terms was investigated for the latter. It was found that the effect of patent activities 
on business performance varied depending on the field of industry, which might be a result of the 
inherent differences in the characteristics of a field in relation to technological innovation. When 
only the main effects of patent activities were considered in the MLR, the results for the sample of 
AI companies showed the existence of positive (+) correlations between the number of patents 
registered per employee and the rate of sales increase per employee, as well as the profitability per 
employee, and also the ratio of R&D expenditure to sales per employee. In comparison, those of the 
sample of Biotech firms demonstrated somewhat different results as negative (-) correlations were 
observed between the number of patents registered per employee and the rate of sales increase (per 
employee), as well as the ratio of R&D expenditure to sales (per employee). This might reflect the 
inherent difference between two distinctive industry fields in perspective of technical advancement 
in relation to the productivity in business operations. Furthermore, it might be worthwhile to note the 
effect of factored patent indices with similar patterns of movements in the MLR analysis as the 
limited interaction between explanatory variables tends to deliver somewhat insufficient information 
in assessing effect of patent activities on business operations. 
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The effect of patent activities on the business performance of firms in three different fields of 
industry was analyzed by exploring the relevant data via multilinear regressions. A research model 
was established based on previous studies and conceptual reasoning, followed by the construction of 
hypotheses to be verified. From the database of the USPTO (United States Patent and Trademark 
Office), 30 companies were selected in three different fields of industry (AI, Biotech, and Power 
plant) based on the number of patent applications filed spanning from 2013 to 2017 (near the top in 
each field). These fields were chosen as each of them show some characteristic features in business 
operation. The business performance of these three clusters of companies was analyzed using the 
following variables: the rate of sales increase (per employee), profitability (per employee) and the 
ratio of R&D expenditure to sales (per employee) in relation to their patent activities. Linear 
regressions as well as multiple linear regressions (MLR) were performed where the effect of two-
way interaction terms was investigated for the latter. It was found that the effect of patent activities 
on business performance varied depending on the field of industry, which might be a result of the 
inherent differences in the characteristics of a field in relation to technological innovation. When 
only the main effects of patent activities were considered in the MLR, the results for the sample of 
AI companies showed the existence of positive (+) correlations between the number of patents 
registered per employee and the rate of sales increase per employee, as well as the profitability per 
employee, and also the ratio of R&D expenditure to sales per employee. In comparison, those of the 
sample of Biotech firms demonstrated somewhat different results as negative (-) correlations were 
observed between the number of patents registered per employee and the rate of sales increase (per 
employee), as well as the ratio of R&D expenditure to sales (per employee). This might reflect the 
inherent difference between two distinctive industry fields in perspective of technical advancement 
in relation to the productivity in business operations. Furthermore, it might be worthwhile to note the 
effect of factored patent indices with similar patterns of movements in the MLR analysis as the 
limited interaction between explanatory variables tends to deliver somewhat insufficient information 
in assessing effect of patent activities on business operations. 
２ 
I. Introduction 
Patents can be a useful way to measure the technical potential of an entity. In today’s world, where 
the system of patents is globally in use, studying the possible effects they have could help analyze 
the current trends and influence of innovation. For companies, innovative development of 
technology and the acquisition of patents is an indispensable factor that influences the entity’s 
competitiveness in the global market. The patent system is, after all, a method for companies to gain 
recognition and get certified rights for their technology. Thus, one important goal for companies 
today is to secure patents in patent system of countries around the world, thereby allowing for 
acquisition in advance of their own technology and the related rights. 
The possession of patents by a company is used not only as a method of proving their technologies 
but also as a legal way for gaining exclusivity in the market. The more technologically advanced a 
patent is, the higher its value as a company asset. Thus, there have been numerous analyses of the 
relationship between patents and the innovation and technological advancement of companies. 
Preexisting studies on the relationship between entities’ patent activity and business performance 
have mainly considered the number of patents simply as a quantitative indicator (Grupp, 1998). 
However, the technological and/or financial value can differ from patent to patent, so mere 
quantitative examination of the applications/acceptances of patents may lead to a conclusion that 
does not reflect the characteristics particular to the firm(s) in question. However, despite the fact that 
the statistical analysis of patents itself is not a method that allows for deduction of the direct effect of 
the invention/innovation itself, it is widely used as there is no other sufficient alternative. Yet, due to 
the characteristic of patents have that a small number of important ones are of exceptionally high 
value while many of the others are not so valuable, it is difficult to assess/compare the quality of 
technology by the difference in the number of patents. 
The present study has been performed to explore the effect of patent activities on business 
performance for three different fields of industry (AI, Biotech and Power plant). In order to do this, 
the patent activity of companies was examined from a quantitative perspective, represented by the 
３ 
number of applications and the number approved, as well as a qualitative perspective, represented by 
the value of the patent, and an analysis was carried out on the relationships between these factors and 
indices of business performance. 
Thirty companies in each field were selected from data of the USPTO (United States Patent and 
Trademark Office) based on the order of the total number of patent applications filed during the 
period from 2013 to 2017. Five patent indices were defined to measure patent activity and used as 
independent variables: the patent application ratio, the patent registration ratio, the percentage of 
accepted patents, the number of patent applications per employee, and the number of patent 
registrations per employee. Meanwhile, business performance was dealt with using three categorical 
indices to be used as dependent variables: the rate of sales increase (per employee), profitability (per 
employee), and the ratio of R&D expenditure to sales. It is hoped that the results obtained through 
this study will help to understand the relationship between patent activities and the business 
performance of firms in different fields of industry. Especially, the existence of distinct discrepancies 
across different fields of industry should be observed in light of understanding the characteristics of 
a field in its business operation in relation to technological innovation. When only the main effects 
of patent indices were considered, the cases for the AI and Biotech industries showed somewhat 
stronger correlations between the patent indices and business indicators. In particular, the latter 
demonstrated meaningful interrelations between them in all the cases studied, indicating the close 
relationship of patent activities in relation to the line of products. By contrast, the MLR analysis 
gave only one case of any meaningful result between patent activity (patent registration ratio) and a 
business indicator (ratio of R&D expenditure to sales per employee). 
This research is organized as follows: Part II consists of previous studies related to this work, and 
Part III describes the research model and hypotheses of the study. Part IV, which is the core section, 
shows the statistical analysis on the hypotheses, and in Part V, discussions are carried out using the 
various results from Part IV. Lastly, in Chapter VI, conclusions and suggestions were made on the 
basis of the results obtained through this study. 
４ 
II. Previous Studies 
1. Patent Rights and Values 
Patent rights have become the most typical and practical means of claiming intellectual property as a 
part of industrial property. Patent rights give exclusive rights for a technology to the holder, thus 
securing the profit to be gained from it. Furthermore, by making public the patented technology, 
technological advancement is catalyzed, and this leads, in turn, to the aim of contributing to 
industrial development. 
The most important reasons for which companies secure patent rights is the fact that a patent gives 
the holder the exclusive rights in the market for 20 years (differs by country) from the date of patent 
application, thereby initially prohibiting technological catchup by other entities (Al-Aali et al.., 
2013). In addition, a patent can be used as a license, allowing for financial gains from royalty fees 
(Arora et al., 2006) and opens up possibilities for technical cooperation with other entities using 
cross-licensing (Di Minin et al., 2013).  
Patents can be a useful way to measure the technical potential of an entity. In today’s world, where 
the system of patents is globally in use, studying the possible effects they have could help analyze 
the current trends and influence of innovation. According to an investigation by Grilches et al. 
(2006), much previous research has only focused on the number of patents to assess the innovative 
productivity of companies. 
Bloom et al. (2002) asserted their opinion that patent citations are a potentially powerful indicator of 
technological innovation. They insisted that doubling of the citation-weighted patent stock could 
result in an increase of total factor productivity by 3%   
Zoltan et al. (1988) introduced a more direct measure to explore the relationship between innovation 
and R&D activities including R&D expenditure and patent inventions. They claimed the difference 
in the relationships between R&D and innovation and R&D and patents.  
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The reason that firms expand the scope of their patents by investing to apply for, register, and 
maintain patents abroad is to dominate international markets by gaining rights to their technology, so 
a patent that has a patent family is one that is very important to the company.  
Patents have both an economically and statistically important impact on firm-level productivity as 
well as market value. While patenting instantly feeds into market values, its impact on productivity 
seems to be quite slower (Suziki, 2011). 
2. Patent Activity and Business Performance of Firms 
The use of intellectual property rights such as patents is closely related to the business strategy and 
technological innovation strategy of a company in various fields, and effective activity in this regard 
is a key factor in strengthening the competitiveness, increasing profit, and facilitating diversification 
of a company. 
Previous research on patents and business has focused mainly on fields such as pharmaceuticals, 
chemistry, machinery, and info-communications where there is a large amount of patent activity. 
According to a study by Arundel et al. (1998), in the case of large European companies, the field 
where the patent ratio was highest for new products was the pharmaceutical industry, followed by 
the office and computer equipment industries. In addition, when Cohen et al. (2000) carried out an 
investigation on the patent ratio of US companies, the patent ratio of new products was found to be 
high for the pharmaceutical industry, the medical equipment industry, and the communication 
equipment industry, compared to other industries. In the case of previous research, also, many 
studies are done on the pharmaceutical and Biotech industries. The reason for this is that in these 
cases, most patents each represent one product, and also, because the technology life cycle is 
relatively long (around 5 or more years), they are suitable for analyzing the influence between 
patents and business performance. 
Wagner et al. (2016) carried out research on data from the pharmaceutical industry in order to find 
６ 
out whether there is a relationship between patent indices and performance in the product market. In 
this study, the association between patent indices and 1) the procedure to apply for a patent while the 
research is yet in an uncertain stage and 2) the procedure where application for a patent is a result of 
product development. This was to examine the influence of a company’s patent activity on the 
process from the commercialization of a product to it becoming an achievement in the 
pharmaceutical industry. The results showed that patents accelerated the commercialization process 
and decreased uncertainty, demonstrating the relationship between patent activity and the stages of 
product development in the pharmaceutical industry. 
In the case of research done by Artz, et al. (2010), 272 companies in 35 industry fields over a period 
of 19 years were analyzed, and the results showed that patents had a positive correlation with R&D 
investment, while it had a negative correlation with profitability and sales increase.   
Ernst (2001) studied the association between patent applications and the ensuing fluctuations in 
company performance. His work demonstrated that more national patent applications was associated 
with an increase in sales with a time-lag of 2 to 3 years following the priority year, whereas 
European patent applications takes it a little bit longer with a lag of 3 years after the priority year. 
Generally, the latter are of higher quality than the former and have a higher impact in the market.  
Ernst et al. (2016) investigated how patent management and indicators of a firm's financial and 
patenting performance are associated across multiple industries. Their empirical results 
demonstrated a positive correlation between two indices of patent management - namely patent 
protection management and patent information management -- and a company's financial 
profitability and its patent portfolio's financial and strategic impact. They insisted that there is a 
strong relationship between patent management and several indices of the performance of a 
company.   
Recently, Ghapar et al. (2014) reported the existence of a notable relationship between patent 
activity and financial performance on the firm level, where the impact was shown to be rather small 
and the signs on the coefficients were mixed.  
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In the work of Andries and Faems (2013), the impact of patent activity on licensing, innovation, and 
financial performance was studied for both SMEs and large firms. They applied Multiple-group path 
analyses to a sample of 358 manufacturing firms. Contrary to their expectations, they found that it 
was not only large firms that benefited from patenting; their research showed that this was also true 
for SMEs for commercialization of product innovations. Furthermore, for both SMEs and large firms, 
higher profit margins were observed when there was contribution from such increased innovation 
performance.  
According to the study on the input made by patent-intensive industries to the EU economy (Office 
for harmonization in the internal market-EU, 2015), large companies were found to be four times 
more likely to hold patent rights than smaller ones; 40% of larger firms have registered rights, while 
only 9% of SMEs did. This also demonstrates that those firms holding patent rights are more likely 
to have better performance compared to those that do not. As SMEs take up an essential part in the 
EU economy, this is an important finding for the 1.8 million SMEs that hold registered patent rights. 
It can be seen from the results that those businesses that hold patent rights have higher revenue per 
employee compared to those that do not, tend to have a higher number of employees, and pay higher 
wages to their workers. Furthermore, it is clearly visible that this correlation is exceptionally strong 
for SMEs. 
The work of McMillan et al. (2013) explored the part that publishing and patenting activities play as 
predictors for new product development for a sample of U.S. firms taken from the pharmaceutical 
industry. In their research, the association between new product development and business 
performance was also studied. They concluded that, on the whole, publishing and patenting progress 
are significantly effective predictors of new product development in this industry. 
A systematic evaluation on patenting behavior was performed for a sample of 50 business firms in 
Germany in the mechanical engineering field (1995). Using a framework with multiple patenting 
indicators, this work pinpointed four different kinds of patenting strategies. Moreover, the 
association between these strategies and business performance was explored. 
８ 
Lee et al. (2015) studied patent activities encompassing university-industry collaboration in 
conjunction with corporate performance. They found the presence of positive effects of patent 
activities from university-industry collaboration resulting in sales increase in global IT companies.  
3. Hypothesis Development 
In general, there exists a considerable mutual relationship between patent activity and firms’ 
business performance. Various studies have previously been performed to explore the various issues 
and arguments arising from their interrelationship from the perspective of technological innovation 
and corporate planning and management. In their work, Lee et al. (2015) developed nine hypotheses 
concerning the relationship between firms’ patents (internally generated and purchased) and their 
performance from different perspectives. Their results show that patents are correlated in different 
ways to firm performance depending on the measure of firm performance considered. Ernst (2001) 
carried out a similar study where he analyzed 50 German machine tool companies from the point of 
view of two simple hypotheses. One of them was related to the effect of the quality of patents on 
firm performance. These led to the development of relevant hypotheses about the relationship 
between patent indices and business performance indicators in the present work, which is slightly 
more complex as three different fields of industry are examined simultaneously. Of these, the first is 
related to identifying the selectiveness of patent indices’ correlation to a specific business 
performance indicator. This is followed by the second hypothesis, which is concerned with 
identifying the direction of the correlation (positive or negative) that exists between a patent index 
and a specific business performance indicator. The third and fourth hypotheses were developed in 
similar contexts by extending the pertinent rationale to reflect the effect when three fields of industry 
are involved.  
According to Art et al. (2010) there is a negative relationship between patent activity and both 
profitability and sales growth. In their study, they developed a number of hypotheses about the 
relationship between patent activity and firms’ performance in connection with R&D spending. Their 
analysis, however, covered 272 companies in 35 industries and overlooked distinctive features of 
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different fields of industry. The fifth hypothesis was developed in the context of exploring the 
relationship between patent indices and business performance indicators in conjunction with R&D 
expenditure. 
To summarize, five hypotheses were developed, considering the distinctiveness of patent activities 
with differences in industrial field put into perspective, which were applied to the research model 
introduced in the beginning of the next chapter.  
Hypothesis 
H1 Patent activity is correlated with business performance. 
1-a: Patent indices will be selectively correlated with a specific business performance indicator 
regardless of difference in field. 
1-b: A patent index correlated with a specific business performance indicator will show the same 
effect regardless of field difference. 
1-c: Patent indices (a patent index) will be positively correlated with a business performance 
indicator for all of those cases of statistical significance in a specific industrial field. 
1-d: A patent index will be positively correlated with a specific business performance indicator 
regardless of difference in field. 
H2 Patent activity is correlated with business performance in relation to R&D productivity. 
2-a A patent index correlated with the sales increase (per employee) will be positively correlated 





1. Research Framework 
A research model has been established to investigate the relationship between the explanatory and 
response variables. Here, patent indices are considered as the explanatory (independent) variables 
whereas measurable indicators of business performance comprise the response (dependent) variables. 
Fig. 1 shows the concept of the research model which lay the basis of this work to determine the 
mathematical relationship by statistical methods (linear regression, multiple linear regression). There 
existed collinearity between some patent indices: between the number of patent applications and the 
patent application ratio, and between the number of patents registered and the patent registered ratio. 
This led to the preclusion of the number of patent applications and the number of patents registered 
in the research model. Additionally, “Profitability” in business performance refers to the ratio of net 
profit to sales. 
 
Fig. 3-1 Research model  
１１ 
2. Dataset 
From the database of the USPTO (United States Patent and Trademark Office), 30 companies were 
selected as representative samples for each of the following three different fields of industry – AI, 
Biotech, and Power plant – based on the number of patent applications filed (near the top in each 
field), spanning from 2013 to 2017. These fields were chosen as each of them show some distinctive 
business features in business operation. The chosen fields were selected as each of them shows a 
distinctive feature when compared to each other in business operations. In the AI field, patent 
activity is not directly related to production of a tangible product with the application of relevant 
technologies. The technologies drawn from patents are rather fused into various areas of the firm’s 
operation; inventory management, production-line automation, etc. This field is characterized by 
high competition, high risks, and a high level of uncertainty, as well as a short technology cycle time 
(TCT) (Matzler et al., 2009). Here TCT refers to a measure for the time that it takes for a new 
technology to be replaced by a newer one. In comparison, the Biotech field is characterized by a 
long TCT (> 5 years) and its patent activity is directly involved with the production of new products 
to enter the market (Judge et al., 1997). In addition, more revenue is allocated to R&D in this field 
than in other fields, as shown in Table 3.1. Different from the AI and Biotech fields, the companies 
in the Power plant field belong to heavy industry, where the outcome of patent activity is rather 
merged into the development of components of bulky and heavy equipment or machineries. They 
also tend to rely on the corporation’s knowhow (tacit knowledge), which has not been disclosed by 
patent applications, to a great degree.  
Tables 3-1 shows the summary of variables used in the present research drawn from the raw data of 
patent activities and those of business performance for three different areas of industry. Depending 
on the field of industry, there exist some distinct discrepancies in the patent data as well as the firm 
performance data. As aforementioned, the Biotech field appears to locate a greater portion of their 




















IV. Data Analysis  
1. Correlation Analysis of Two Variables 
The correlation coefficient statistically measures the strength of the relationship that exists between 
the relative movements of two variables. Its value ranges from -1.0 to 1.0. The correlation coefficient 
provides a valuable piece of information in understanding the effect of one variable on another, 
which could be effectively used to make predictions without undue difficulties. In this work, 
correlation coefficients between major variables were statistically measured by running STATA, 
which gave results in the form of a correlation matrix. Tables 4-1, 4-2 and 4-3 present the correlation 
matrices for the companies in the AI, Biotech and Power plant fields, respectively. These matrices 
provide the basic information concerning the existence of a correlation between two variables (input 
data), which could be used as a diagnostic for advanced analysis. In this work, it was used as a 
criterion to select those cases to run linear regressions on; the ones chosen had a correlation 















































































2. Linear Regressions 
One on one linear regressions were carried out for those cases where the correlation coefficient 
between an explanatory variable (patent index) and a response variable (business indicator) was 
greater than 0.5, as aforementioned. Table 4-4 is a summary of the linear regressions for the cases 
considered. As shown, thirteen cases were considered across companies from different industries, 
including the case where all companies were combined together into one sample (90 companies). 
Depending on the field, there exist discrepancies as to whether a result presents any statistical 
significance. This could be identified by checking the corresponding p-values of the regression table. 
By examining the results of these linear regressions, one could readily predict the influence on the 
variation of a specific variable even with the involvement of another variable as dealt in 
multivariable analysis.  
Figs. 4-1, 4-2, and 4-3 are the linear regression results for the companies in each field as well as for 
all companies ignoring the categorical distinction of industry. The presented cases are those where 
the p-values fall within the acceptable limit of 0.05 for statistical significance. Additional results are 









































































































































































































































































































3. Multilinear Regression (MLR) 
Multiple linear regressions (MLR) have been carried out to explore the relationship of a response 
variable (business indicator) against explanatory variables (patent indices). This is a well-known 
statistical means to predict the behavior of a response variable with variations in explanatory 
variables. The eventual goal of the MLRs in this work is to identify (validate) the hypotheses made 
in the research framework (given it appropriately models the relationship that exists between the 
explanatory (independent) variables and response (dependent) variables. 
3.1 Multiple linear regressions (patent indices vs business parameters) 
The results of the MLRs are presented for each of the six business parameters (indicators) against 
five patent indices. The six business parameters were as follows: rate of sales increase, rate of sales 
increase per employee, profitability, profitability per employee, ratio of R&D expenditure to sales, 
and ratio of R&D expenditure to sales per employee. The patent indices comprising the explanatory 
variables were the following: patent application ratio, patent registration ratio, percentage of 
accepted patents, number of patent applications per employee, and number of patents registered per 
employee. Here, the patent application ratio refers to the ratio of the number of patent applications 
filed by a specific company to the total number of patent applications filed by the thirty companies 
in the sample of the same field. The patent registration ratio has been defined in a similar way. 
3.1.1 AI 
Tables 4-5, 4-6, and 4-8 give the summaries of the MLR regression results, where a number of 
significant statistical indices (p-values, R-squared, root MSE, etc.) are listed. As shown, half of the 
cases among the six cases considered gave meaningful results conducive to confirming the validity 
of the hypotheses developed in this work (hypothesis 1-a, 1-c). For these cases, the p-values are 
highlighted in light green shades. It should be noted that the inclusion of two-way interaction terms 
slightly improved the R-squared value as compared to when only the main effects of the patent 
indices were considered in the MLR; the value changed from 0.988 to 0.9907, Table 4-8. 
２３ 
Table 4-5 Rate of sales increase per employee (AI) 
Rate of sales increase per employee (Case 1) 
Description 
Without Interaction 
Coefficients p-value S.E of Regression 
Patent Application Ratio -0.0000351 0.853 0.0001873 
Patent Registration Ratio 0.000000834 0.996 0.0001734 
Percentage of Accepted Patents -0.00000893 0.528 0.000014 
Number of Patent Applications per Employee -9.18E-04 0.391 0.0010511 
Number of Patents Registered per Employee 0.0095397 0.000 0.0014274 
_cons 0.00000405 0.487 0.00000574 
Number of Observations 30 
Sum squared resid 2.6794E-09 
R-Squared 0.9745 
Adjusted R-squared 0.9691 
Root MSE 0.000011 
p-value(F) 0.0000 
 
Table 4-6 Profitability per employee (AI) 
Profitability per employee (Case 1) 
Description 
Without Interaction 
Coefficients p-value S.E of Regression 
Patent Application Ratio 0.000288 0.405 0.0003398 
Patent Registration Ratio -0.0003725 0.248 0.0003145 
Percentage of Accepted Patents -0.00000979 0.702 0.0000253 
Number of Patent Applications per Employee -3.38E-03 0.089 0.0019069 
Number of Patents Registered per Employee 0.0352545 0.000 0.0025894 
_cons 0.00000654 0.536 0.0000104 
Number of Observations 30 
Sum squared resid 8.8174E-09 
R-Squared 0.9938 
Adjusted R-squared 0.9925 
Root MSE 0.000019 
p-value(F) 0.0000 
２４ 
The results shown in Table 4-8 involve additional terms to examine the two-way interaction effects 
between the original variables. The two-way interaction effects were tested in addition to the main 
effects in the MLR analysis, where applicable. Table 4-7 shows the list of the two-way interactions 
terms used in the MLR analysis; ai1, ai2, ai3, ai4, ai5……..ai10.  
Table 4-7 Two-way interaction terms 
Patent Application ratio Number of patents registered per employee ai1 
Patent Registered Ratio Number of patents registered per employee ai2 
Percentage of Accepted Patents Number of patents registered per employee ai3 
Number of Patent Applications per Employee Number of patents registered per employee ai4 
Patent Registered Ratio Patent Application ratio ai5 
Percentage of Accepted Patents Patent Application ratio ai6 
Number of Patent Applications per Employee Patent Application ratio ai7 
Percentage of Accepted Patents Patent Registered Ratio ai8 
Number of Patent Applications per Employee Patent Registered Ratio ai9 
Number of Patent Applications per Employee Percentage of Accepted Patents ai10 
 
The above two-way interaction terms constructed from the original explanatory variables (patent 
indices) could produce an effect that is different from what was observed when only the original 
explanatory variables were involved in the MLR analysis. 
  
２５ 
Table 4-8 Ratio of R&D expenditure to sales per employee (AI) 
Ratio of R&D expenditure to sales per employee (Case 2) 
Description 













Patent Application Ratio 0.000064 0.398 0.0000743 0.0000599 0.45 0.0000779 














Number of Patent Applications per 
Employee 
0.0004384 0.304 0.000417 0.0041929 0.005 0.0013524 
Number of Patents Registered per 
Employee 




ai1          
ai2          
ai3      0.0395098 0.007 0.0134042 




ai5         
ai6          
ai7          
ai8          
ai9          
ai10          
_cons -1.38E-07 0.952 0.00000228 -2.28E-07 0.911 0.00000203 
Number of Observations 30 30 
Sum squared resid 4.2169E-10 2.9966E-10 
R-Squared 0.9901 0.993 
Adjusted R-squared 0.988 0.9907 
Root MSE 0.0000042 0.0000037 





Tables 4-9 to 4-14 give the summaries of the MLR regression results for the Biotech companies. As 
compared to the cases of AI, all cases gave statistically meaningful results only by considering the 
main effects of the patent indices. The inclusion of two-way interaction effects also produced 
statistically meaningful results in half of the cases, but these appear to deviate from the (original) 
research model and add complexity in analyzing the correlation between patent indices and business 
performance indicators. As shown in Tables 4-10, 4-12, 4-14, the introduction of two-way interaction 
terms was only effective in boosting the R-squared values.  
The results given by Tables 4-9 to 4-14 clearly demonstrate the validity of hypothesis 1-a as different 
patent indices are correlated to a specific business performance indicator as already shown in the AI 
cases. Also, as shown in Table 4-14, there exists a negative correlation between the number of 
patents registered per employee and the ratio of R&D expenditure per employee. This is the opposite 
of the result shown for the same case in AI (Table 4-11), which negates hypothesis 1-b. 
Table 4-9 Rate of sales increase (Biotech) 
Rate of sales increase (Case 3) 
Description 
Without Interaction 
Coefficients p-value S.E of Regression 
Patent Application Ratio -5.090797 0.035 2.273762 
Patent Registration Ratio 3.434153 0.047 1.642348 
Percentage of Accepted Patents -0.2846021 0.176 0.2039517 
Number of Patent Applications per Employee 5.18E+00 0.000 0.6159623 
Number of Patents Registered per Employee -6.765492 0.000 0.8572694 
_cons 0.2638593 0.037 0.1197856 
Number of Observations 30 
Sum squared resid 0.23269042 
R-Squared 0.7993 
Adjusted R-squared 0.7575 
Root MSE 0.09847 
p-value(F) 0.0000 
２７ 
Table 4-10 Rate of sales increase per employee (Biotech) 
Rate of sales increase per employee (Case 2) 
Description 




















Patent Registration Ratio 0.0323652 0.218 0.0255726 0.0894717 0.039 0.0401758 







Number of Patent Applications per 
Employee 








0.000 0.0133483 1.155693 0.000 0.1928623 
ai1       
ai2    32.45923 0.002 9.127575 
ai3    -2.467339 0.000 0.3934796 
ai4    0.087573 0.000 0.0152937 
ai5       
ai6       
ai7    21.42666 0.005 6.756756 
ai8       
ai9    -42.66788 0.003 12.58363 
ai10    1.663532 0.000 0.3021723 
_cons 1.01E-03 0.593 0.0018651 1.22E-03 0.28 0.0010921 
Number of Observations 30 30 
Sum squared resid 5.64E-05 3.32E-06 
R-Squared 0.7089 0.9821 
Adjusted R-squared 0.6483 0.9712 
Root MSE 0.00153 0.00044 
p-value(F) 0.000 0.000 
  
２８ 
Table 4-11 Profitability (Biotech) 
Profitability (Case 1) 
Description 
Without Interaction 
Coefficients p-value S.E of Regression 
Patent Application Ratio 5.605475 0.313 5.434165 
Patent Registration Ratio -3.845715 0.337 3.925119 
Percentage of Accepted Patents 0.6377124 0.203 0.4874332 
Number of Patent Applications per Employee -6.95E+00 0.000 1.472115 
Number of Patents Registered per Employee 8.921947 0.000 2.048826 
_cons -0.047425 0.87 0.2862809 
Number of Observations 30 
Sum squared resid 1.32908872 
R-Squared 0.5779 
Adjusted R-squared 0.49 





Table 4-12 Profitability per employee (Biotech) 
Profitability per employee (Case 2) 
Description 













Patent Application Ratio 0.0669617 0.266 0.0588474 0.0978418 0.175 0.0693263 







Percentage of Accepted Patents 0.0034893 0.515 0.0052785 0.0037812 0.292 0.00348 




0.000 0.0159418 1.157497 0.000 0.2500103 
Number of Patents Registered per 
Employee 
0.1236194 0.000 0.0221871 -1.812532 0.000 0.33484 
ai1          
ai2     -48.89574 0.006 15.84694 
ai3     3.814101 0.000 0.6831438 
ai4     
-
0.1581381 0.000 0.0265524 
ai5          
ai6          
ai7     -32.17791 0.013 11.73082 
ai8          
ai9     64.15963 0.009 21.8472 
ai10     -2.487012 0.000 0.5246198 
_cons -1.78E-03 0.572 0.0031002 -1.67E-03 0.391 0.0018961 
Number of Observations 30 30 
Sum squared resid 1.56E-04 1.04E-05 
R-Squared 0.6305 0.9752 
Adjusted R-squared 0.5535 0.9601 
Root MSE 0.00255 0.00076 




Table 4-13 Ratio of R&D expenditure to sales (Biotech) 
Ratio of R&D expenditure to sales (Case 3) 
Description 
Without Interaction 
Coefficients p-value S.E of Regression 
Patent Application Ratio -6.335762 0.123 3.966079 
Patent Registration Ratio 4.339237 0.143 2.864715 
Percentage of Accepted Patents -0.2731155 0.45 0.355749 
Number of Patent Applications per Employee 8.35E+00 0.000 1.074411 
Number of Patents Registered per Employee -10.51592 0.000 1.495318 
_cons 0.3593922 0.098 0.2089397 
Number of Observations 30 
Sum squared resid 0.707964003 
R-Squared 0.7887 
Adjusted R-squared 0.7447 





Table 4-14 Ratio of R&D expenditure to sales per employee (Biotech) 
Ratio of R&D expenditure to sales per employee (Case 2) 
Description 













Patent Application Ratio 
-
0.0987486 
0.238 0.0816522 0.1175787 0.075 0.0624035 




Percentage of Accepted Patents 
-
0.0046333 
0.533 0.007324 0.0019911 0.7 0.0050898 
Number of Patent Applications per 
Employee 
0.1413128 0.000 0.0221196 -0.787919 0.01 0.2739608 




0.000 0.0307851 1.738835 0.002 0.4837998 
ai1          
ai2           
ai3     -3.406897 0.001 0.8865906 
ai4     0.209826 0.000 0.0445119 
ai5          
ai6          
ai7     -5.883163 0.000 0.7886241 
ai8          
ai9     4.676737 0.000 0.8186225 
ai10     1.638375 0.004 0.4972943 
_cons 2.44E-03 0.576 0.0043016 -2.06E-03 0.45 0.0026678 
Number of Observations 30 30 
Sum squared resid 3.00E-04 3.11E-05 
R-Squared 0.7061 0.9696 
Adjusted R-squared 0.6449 0.9536 
Root MSE 0.00354 0.00128 




3.1.3 Power plant 
Table 4-15 shows the MLR result of the case involving those companies in the Power plant industry. 
As shown, only one case presented a meaningful result with statistical significance (Table 4-15) 
which upholds hypothesis 1-a. As compared to the previous cases of AI and Biotech, the MLR 
analyses show a rather weak correlation between the patent indices and the business performance 
indicator. As aforementioned in Chapter III, the companies in the Power plant field belong to heavy 
industry where the effect of patent activity is rather limited in relation to firms’ performance. The 
relevant patent technologies claimed and put into practice are generally directed to the development 
of components (parts) of bulky and/or heavy equipment or machineries.  
More results are given in Appendix B. 
Table 4-15 Ratio of R&D expenditure to sales per employee (Power plant) 
Ratio of R&D expenditure to sales per employee  (Case 3) 
Description 
Without Interaction 
Coefficients p-value S.E of Regression 
Patent Application Ratio 0.0000175 0.184 0.0000128 
Patent Registration Ratio -0.0000361 0.027 0.0000153 
Percentage of Accepted Patents 0.000000686 0.714 0.00000185 
Number of Patent Applications per Employee -2.15E-04 0.55 0.0003538 
Number of Patents Registered per Employee 0.0008542 0.144 0.0005656 
_cons 0.000000322 0.813 0.00000134 
Number of Observations 30 
Sum squared resid 2.217E-11 
R-Squared 0.4562 
Adjusted R-squared 0.3429 





3.1.4 All companies combined 
The MLR results when all the companies were considered together regardless of difference in field 
are given by Tables 4-16 through 4-21. As in the cases of Biotech, all business performance 
indicators were correlated with patent indices in conformity with hypothesis 1-a. When compared 
with the cases of AI and Biotech, there exists a negative correlation between the number of patents 
registered per employee and the ratio of R&D expenditure per employee, similar to the Biotech field. 
Furthermore, introduction of the interaction effects deems unnecessary as it merely improves R-
squared values and draws away from the original research model as observed in the cases of Biotech.  
Table 4-16 Rate of sales increase (All companies) 
Rate of sales increase  (Case 1) 
Description 
Without Interaction 
Coefficients p-value S.E of Regression 
Patent Application Ratio -2.62041 0.064 1.394163 
Patent Registration Ratio 1.463218 0.21 1.159082 
Percentage of Accepted Patents -0.0409492 0.461 0.0552303 
Number of Patent Applications per Employee 5.46E+00 0.000 0.5938859 
Number of Patents Registered per Employee -7.135073 0.000 0.8286443 
_cons 0.0866389 0.008 0.032013 
Number of Observations 90 
Sum squared resid 0.85594788 
R-Squared 0.5523 
Adjusted R-squared 0.5257 





Table 4-17 Rate of sales increase per employee (All companies) 
Rate of sales increase per employee (Case 2) 
Description 




















Patent Registration Ratio 0.0106297 0.284 0.0098517 0.169228 0.003 0.0544145 




Number of Patent Applications per 
Employee 








0.000 0.0070431 0.3879916 0.000 0.0864373 
ai1          
ai2     44.40794 0.000 7.362062 




ai4     0.0287027 0.000 0.0060268 
ai5          
ai6          
ai7     29.46768 0.000 5.827738 




ai9     -56.28602 0.000 9.905648 
ai10     0.7051472 0.000 0.1339076 
_cons -1.95E-04 0.477 0.0002721 1.78E-04 0.235 0.0001485 
Number of Observations 90 90 
Sum squared resid 6.18E-05 1.03E-05 
R-Squared 0.6929 0.9488 
Adjusted R-squared 0.6746 0.9409 
Root MSE 0.00086 0.00037 
p-value(F) 0.0000 0.0000 
  
３５ 
Table 4-18 Profitability (All companies) 




s p-value S.E of Regression 
Patent Application Ratio -0.4162806 0.896 3.175517 
Patent Registration Ratio 1.971701 0.457 2.640068 
Percentage of Accepted Patents -0.4233329 0.001 0.1257994 
Number of Patent Applications per Employee -6.84E+00 0.000 1.352708 
Number of Patents Registered per Employee 9.183826 0.000 1.887423 
_cons 0.4454232 0 0.0729169 
Number of Observations 90 
Sum squared resid 4.44067848 
R-Squared 0.3171 
Adjusted R-squared 0.2765 





Table 4-19 Profitability per employee (All companies) 
Profitability per employee (Case 2) 
Description 













Patent Application Ratio 0.0193262 0.327 0.0196185 0.1464946 0.002 0.0456633 







Percentage of Accepted Patents 
-
0.0000865 
0.912 0.0007772 0.0005542 0.194 0.0004232 




0.000 0.0083571 0.4265503 0.000 0.1027182 




ai1          
ai2     -66.26188 0.000 11.7834 
ai3     1.636311 0.000 0.2850143 




ai5          
ai6          
ai7     -43.75152 0.000 9.327629 
ai8     0.1601397 0.031 0.0727796 
ai9     83.66548 0.000 15.85456 
ai10     -1.070316 0.000 0.2143267 
_cons 2.62E-04 0.562 0.0004505 -2.75E-04 0.252 0.0002376 
Number of Observations 90 90 
Sum squared resid 1.69E-04 2.64E-05 
R-Squared 0.6084 0.939 
Adjusted R-squared 0.5851 0.9295 
Root MSE 0.00142 0.00059 




Table 4-20 Ratio of R&D expenditure to sales (All companies) 
Ratio of R&D expenditure to sales (Case 2) 
Description 













Patent Application Ratio -2.46844 0.112 1.539055 -1.694085 0.273 1.533796 
Patent Registration Ratio 2.037679 0.115 1.279542 1.017317 0.442 1.318276 




Number of Patent Applications per 
Employee 
9.048471 0.000 0.6556069 7.728671 0.000 0.847471 
Number of Patents Registered per 
Employee 
-11.33257 0.000 0.9147633 -8.018474 0.000 1.659086 
ai1          
ai2       
 
  
ai3       
 
  
ai4     -1.456803 0.02 0.6152953 
ai5          
ai6          
ai7       
 
  
ai8       
 
  
ai9       
 
  
ai10       
 
  
_cons 1.50E-01 0 0.0353401 1.46E-01 0 0.0344542 
Number of Observations 90 90 
Sum squared resid 1.04E+00 9.77E-01 
R-Squared 0.7678 0.7825 
Adjusted R-squared 0.7539 0.7667 
Root MSE 0.11144 0.1085 




Table 4-21 Ratio of R&D expenditure to sales per employee (All companies) 
Ratio of R&D expenditure to sales per employee (Case 2) 
Description 




















Patent Registration Ratio 0.0211138 0.354 0.0226753 0.3948232 0.002 0.1208832 
Percentage of Accepted Patents 0.0003064 0.777 0.0010805 -0.000822 0.166 0.0005873 
Number of Patent Applications per 
Employee 








0.000 0.0162109 0.8697075 0.000 0.1920226 
ai1          
ai2     99.42748 0.000 16.35499 
ai3     -2.190855 0.000 0.3955909 
ai4     0.0780281 0.000 0.0133886 
ai5          
ai6          
ai7     65.69161 0.000 12.94645 
ai8     
-
0.2607383 0.012 0.1010158 
ai9     -125.8089 0.000 22.00563 
ai10     1.544603 0.000 0.2974787 
_cons -4.28E-04 0.496 0.0006263 3.97E-04 0.232 0.0003298 
Number of Observations 90 90 
Sum squared resid 3.28E-04 5.08E-05 
R-Squared 0.6924 0.9523 
Adjusted R-squared 0.6741 0.9448 
Root MSE 0.00197 0.00081 




4. Multilinear Regression with Factor Analysis 
4.1 Factor analysis of patent indices 
To identify closely interrelated variables and to test them collectively by forming so-called “factors” 
(groups of collective variables), factor analysis was conducted for patent indices. By performing 
factor analysis, the patent indices (explanatory variables) were grouped into three distinct factors 
representative of patent indices with similar patterns of responses observed in the dataset. Each 
factor formed by conducting factor analysis captures a certain amount of the overall variance in the 
patent indices, which are listed in order of the amount of variation they explain. 
Table 4-22 Result of factor analysis for patent indices 
 
Table 4.22 shows a result of the factor analysis performed on the patent indices of all companies. 
Varimax rotation is used to maximize the sum of the variances of the squared loadings. In factor 
analysis, this is an important second step to clarify the relationship among factors. As can be easily 
identified, each factor represents a distinctive feature of patent indices grouped together. The first 
factor (Factor 1) can be interpreted as representing the patent productivity, the second one (Factor 2) 
as the employee patent productivity, and the last one (Factor 3) as the patent innovativeness. 
4.2 Multiple linear regressions 
The following are some of the results of the MLR analysis using the factored patent indices drawn 
from each of the datasets of the AI, Biotech, and Power plant industries, as well as all companies 
combined. It is worthwhile to note that, as in the corresponding cases without factor analysis, it 
４０ 
deems examining the main effects were enough to identify the correlation between explanatory 
variables (factored patent indices) and response variables (business performance indicators). 
Especially, in the AI cases, it was observed that there exists a close similarity between the 
corresponding cases in such a way that the response variables (business parameters) are correlated 
with the explanatory variables (patent indices) from the perspective of involving the main effects to 
produce results of statistical significance. In comparison, the Biotech cases showed no correlation 
results of statistical significance, which is totally different from those cases without factor analysis. 
It appears that the factored patent indices fail to carry sufficient information to be correlated with a 
business performance indicator by the MLR analysis as the factored patent indices are represented 
by a single number, called a “factor score.” 
It is also interesting to note the carryover effect of the dominant influence of a specific field into the 
MLR results of all companies (90 companies) as witnessed by Tables 4-28 to 4-31.  
Table 4-23 Rate of sales increase per employee (AI) 
Rate of sales increase per employee (Case 3) 
Description 
Without Interaction 
Coefficients p-value S.E of Regression 
AIP1 -0.00000424 0.076 0.0000023 
AIP2 0.0000588 0.000 0.00000232 
AIP3 0.00000864 0.001 0.00000232 
_cons 1.41E-05 0 0.00000226 
Number of Observations 30 
Sum squared resid 3.9751E-09 
R-Squared 0.9621 
Adjusted R-squared 0.9577 






Table 4-24 Profitability per employee (AI) 
Profitability per employee (Case 2) 
Description 
Without Interaction With Interaction 
Coefficients p-value S.E of Regression Coefficients p-value S.E of Regression 
AIP1 -0.0000147 0.022 0.000006 -9.10E-06 0.012 3.34E-06 
AIP2 0.0002187 0.000 0.00000606 0.0001691 0.000 7.49E-06 
AIP3 0.0000292 0.000 0.00000607 0.0000297 0.000 4.41E-06 
ai1           
ai2      0.0000684 0.000 9.59E-06 
ai3      -0.0000177 0.025 7.44E-06 
_cons 5.35E-05 0 5.90E-06 0.0000533 0 3.19E-06 
Number of Observations 30 30 
Sum squared resid 2.7173E-08 7.34E-09 
R-Squared 0.9808 0.9948 
Adjusted R-squared 0.9786 0.9938 
Root MSE 0.000032 1.70E-05 
p-value(F) 0.0000 0.0000 
 
Table 4-25 Rate of R&D expenditure to sales per employee (AI) 
Ratio of R&D expenditure to sales per employee (Case 2) 
Description 







AIP1 -0.00000282 0.004 0.000000908 -2.37E-06 0.005 7.64E-07 
AIP2 0.000038 0.000 0.000000916 0.0000325 0.000 1.73E-06 
AIP3 0.00000429 0.000 0.000000918 0.00000362 0.000 7.85E-07 
ai1           
ai2      0.00000781 0.001 2.19E-06 
ai3        
 
  
_cons 1.09E-05 0 8.92E-07 0.0000108 0 7.41E-07 
Number of Observations 30 30 
Sum squared resid 6.21E-10 4.11E-10 
R-Squared 0.9854 0.9903 
Adjusted R-squared 0.9837 0.9888 
Root MSE 0.0000049 4.10E-06 




Table 4-26 Rate of sales increase (Biotech) 
Rate of sales increase (Case 4) 
Description 




Coefficients p-value S.E of Regression 
BTP1 -0.0457607 0.222 0.036568 -2.33E-01 0.008 8.04E-02 
BTP2 0.0560512 0.139 0.0367512 0.2220999 0.000 5.45E-02 
BTP3 -0.0035411 0.924 0.0368226 -0.2096912 0.002 5.86E-02 
ai1           
ai2      -0.6275612 0.001 0.1677102 
ai3      0.1612382 0.007 0.054851 
_cons 1.36E-01 0.001 0.0359501 0.13786 0 2.78E-02 
Number of Observations 30 30 
Sum squared resid 1.01E+00 5.58E-01 
R-Squared 0.1305 0.5186 
Adjusted R-squared 0.0302 0.4183 
Root MSE 0.19691 1.52E-01 
p-value(F) 0.2952 0.0023 
 
Table 4-27 Ratio of R&D expenditure to sales per employee (Power plant) 






PPP1 -4.39E-07 0.025 0.000000184 
PPP2 0.000000587 0.004 0.000000186 
PPP3 2.86E-09 0.988 0.000000193 
_cons 1.02E-06 0 0.000000181 
Number of Observations 30 
Sum squared resid 2.5502E-11 
R-Squared 0.3744 
Adjusted R-squared 0.3022 





Table 4-28 Rate of sales increase (All companies) 
Rate of sales increase (Case 2) 
Description 
Without Interaction Without Interaction 
Coefficients p-value S.E of Regression Coefficients p-value S.E of Regression 
P1 -0.024531 0.102 0.0148598 3.14E-02 0.08 1.77E-02 
P2 0.0432362 0.005 0.0149337 0.0487257 0.000 1.34E-02 
P3 -0.0064331 0.67 0.0150378 0.0009656 0.943 1.35E-02 
ai1        
 
  
ai2      -0.2760183 0.000 0.0578524 
ai3        
 
  
_cons 8.13E-02 0 0.0147768 0.0816007 0 1.32E-02 
Number of Observations 90 90 
Sum squared resid 1.69E+00 1.33E+00 
R-Squared 0.116 0.3028 
Adjusted R-squared 0.0852 0.2699 
Root MSE 0.14018 1.25E-01 
p-value(F) 0.0137 0.0000 
  
４４ 
Table 4-29 Rate of sales increase per employee (All companies) 
Rate of sales increase per employee (Case 2) 
Description 
Without Interaction Without Interaction 
Coefficients p-value S.E of Regression Coefficients p-value S.E of Regression 
P1 -0.0000924 0.541 0.0001507 5.26E-04 0.000 1.25E-04 
P2 0.0005408 0.001 0.0001514 0.0005798 0.000 9.00E-05 
P3 -0.0001088 0.477 0.0001525 -0.0011468 0.000 2.05E-04 
ai1        
 
  
ai2      -0.0050438 0.000 0.0004047 
ai3      0.0003069 0.000 0.000049 
_cons 2.10E-04 0.164 0.0001498 0.0002158 0.017 8.84E-05 
Number of Observations 90 90 
Sum squared resid 1.74E-04 5.91E-05 
R-Squared 0.1368 0.7066 
Adjusted R-squared 0.1067 0.6891 
Root MSE 0.00142 8.40E-04 
p-value(F) 0.0053 0.0000 
 
Table 4-30 Ratio of R&D expenditure to sales (All companies) 
Ratio of R&D expenditure to sales (Case 2) 
Description 
Without Interaction Without Interaction 
Coefficients p-value S.E of Regression Coefficients p-value S.E of Regression 
P1 -0.0154037 0.457 0.0206009 3.24E-02 0.131 2.12E-02 
P2 0.1156375 0.000 0.0207035 0.1169253 0.000 1.52E-02 
P3 -0.0226066 0.281 0.0208478 -0.1915523 0.000 3.48E-02 
ai1        
 
  
ai2      -0.5475956 0.000 0.0685249 
ai3      0.0480316 0.000 0.0082999 
_cons 1.48E-01 0 2.05E-02 0.1486804 0 1.50E-02 
Number of Observations 90 90 
Sum squared resid 3.25E+00 1.69E+00 
R-Squared 0.2768 0.6228 
Adjusted R-squared 0.2516 0.6004 
Root MSE 0.19435 1.42E-01 
p-value(F) 0.0000 0.0000 
 
４５ 
Table 4-31 Ratio of R&D expenditure to sales per employee (All companies) 
Ratio of R&D expenditure to sales per employee(Case 2) 
Description 
Without Interaction Without Interaction 
Coefficients p-value S.E of Regression Coefficients p-value S.E of Regression 
P1 -0.000215 0.518 0.0003312 1.13E-03 0.000 2.84E-04 
P2 0.0015674 0.000 0.0003328 0.0016531 0.000 2.03E-04 
P3 -0.0002439 0.469 0.0003351 -0.0024685 0.000 4.64E-04 
ai1           
ai2      -0.0109299 0.000 0.0009148 
ai3      0.0006585 0.000 0.0001108 
_cons 5.00E-04 0.132 3.29E-04 0.0005128 0.012 2.00E-04 
Number of Observations 90 90 
Sum squared resid 8.39E-04 3.02E-04 
R-Squared 0.2119 0.7165 
Adjusted R-squared 0.1844 0.6996 
Root MSE 0.00312 1.90E-03 
p-value(F) 0.0001 0.0000 
 
5. Dummy Variables 
To identify the categorical distinction between the datasets used in this work, MLR analyses have 
been carried out with the inclusion of two dummy variables. The following tables were generated by 
such analyses (applied to Ratio of R&D expenditure to sale), where the datasets of all companies 
were used by assigning either 1 or 0 to two dummy variables. As shown in the following tables, 
some meaningful results of statistical significance were obtained. Table 4-32 was obtained when the 
first dummy variable (dummy 1) was defined as AI =1 and others = 0 (other remaining fields) while 
the second dummy variable (dummy 2) was defined as Biotech =1 and others = 0 (other remaining 
fields).  
Meanwhile, Table 4-33 shows the results for when the first dummy variable (dummy 1) was defined 
as AI =1 and others = 0 (other remaining fields) while the second dummy variable (dummy 2) was 
defined as Power plant =1 and others = 0 (other remaining fields).  
These results indicate that there exists a categorical distinction among the fields considered in this 
work; AI, Biotech, and Power plant.  
  
４６ 
















a. Dependent Variable: Q7




1 .892a 0.796 0.779 0.105595201 0.796 45.831
Sum of
Squares
df Mean Square F Sig.
Regression 3.577 7 0.511 45.831 .000b
Residual 0.914 82 0.011
Total 4.492 89
a. Dependent Varable: Q7





B Std. Error Beta Tolerance
(Constant) 0.061 0.056 1.093 0.278
D2_Dummy
1
0.049 0.036 0.104 1.373 0.173 0.057
D2_Dummy
2
0.107 0.032 0.226 3.317 0.001 0.058
P1 -1.711 1.502 -0.14 -1.139 0.258 0.346
P2 0 0 0.118 0.931 0.355 0.018
P3 -0.023 0.075 -0.023 -0.309 0.758 0.018
P4 8.572 0.646 4.899 13.274 0 0.37
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Change Statistics




















a. Dependent Variable: Q7




1 .892a 0.796 0.779 0.105595201 0.796 45.831
Sum of
Squares
df Mean Square F Sig.
Regression 3.577 7 0.511 45.831 .000b
Residual 0.914 82 0.011
Total 4.492 89
a. Dependent Varable: Q7





B Std. Error Beta Tolerance
(Constant) 0.168 0.045 3.747 0
D3_Dummy
1
-0.058 0.031 -0.122 -1.865 0.066 0.057
D3_Dummy
2
-0.107 0.032 -0.226 -3.317 0.001 0.058
P1 -1.711 1.502 -0.14 -1.139 0.258 0.346
P2 0 0 0.118 0.931 0.355 0.018
P3 -0.023 0.075 -0.023 -0.309 0.758 0.018
P4 8.572 0.646 4.899 13.274 0 0.534
P5 -10.812 0.892 -4.441 -12.117 0 0.558
D3_Dummy1: AI=1, Other=0; D3_Dummy2: PP=1, Other=0
Variables Entered/Removeda
Model Summary












As can be seen in the details of the methods of analysis as well as the corresponding results given in 
the previous chapter, this work has been carried out largely in three steps for its study by statistical 
analysis; correlation analysis between variables, linear and multiple linear regressions (MLR), and 
linear and multiple linear regressions (MLR) with factor analysis. 
1. Correlation Analysis 
As previously mentioned in Chapter IV, this statistically gives the strength of the relationship of two 
variables in conjunction with their movements as observed in a dataset. The correlation coefficient 
could be used effectively to deduce the effect of one variable onto another and to explore the 
conceptual reasoning in understanding the relationship that exists between them. The correlation 
matrices, summarizing the correlation coefficients between two variables, provided the initial 
intuitive understanding concerning the variation of variables as they are given in a dataset. The 
criterion used – to select those cases with the correlation coefficient greater than 0.5 – deems to be 
reasonable judging from the results obtained in the linear regressions as well as the multiple linear 
regressions as presented in Chapter IV.   
2. Linear and Multiple Linear Regressions (MLR) 
2.1. Linear regressions 
The linear regression results demonstrated the existence of differences across the field which 
demonstrate any meaningful statistical significance (p <0.5). It was observed that six cases in AI fall 
within the criterion, whereas four cases in Biotech and one case in the Power plant industry satisfy 
the criterion. When all cases are considered at once (90 companies data considered at once ignoring 
the field differences), it was found that eight cases are to be considered. Of the eight cases, there 
were three where the p-values were lower than 0.05 in both AI and Biotech. In addition, there were 
three additional cases where p-values were lower than 0.05 in AI only. This might be suggesting that 
the prevailing effect of a field (or two fields) is sustained even after all companies are considered 
４９ 
together, and the blending of the remaining data set was not enough to overcome the effect carried 
over. It appears that the statistical outcome of the linear regressions was carried over even when 
additional variables were introduced in the analysis to identify the effect of explanatory variables 
onto a response variable, as witnessed in the MLR analysis discussed below. 
2.2. Multiple Linear Regressions (MLR)  
As given in Chapter IV, concerning the detailed data analyses of the MLR and their results, there 
were distinctive discrepancies observed across different fields among variables as to the effect of 
patent indices onto a business parameter. Table 5-1 (a) gives a summary of the MLR results 
performed in this work for the companies in three different fields of industry (AI, Biotech, Power 
plant) and for all companies combined. Here, in Table 5-1 (b), M stands for the case when only the 
main effects were considered, and F represents the case where the final result where the two-way 
interaction effects were considered on the basis of the existence of two-way interaction terms 
identified in IE. IE gives the result of an intervening calculation step for identifying those of 
interaction terms with any statistical significance (p<0.5). 
Table 5-1(a) Summary of MLR regression results (without factor analysis): cases identified for 
interaction effects in conjunction with Table 5-1(b)  
 











Rate of sales increase  5 3 5 1 
Rate of sales increase per employee 1 2 5 2 
Profitability  5 1 6 3 
Profitability per employee  1 2 6 2 
Ratio of R&D expenditure to sales  5 3 5 2 
Ratio of R&D expenditure to sales per 





Table 5-1(b) Summary of MLR regression results (without factor analysis): cases identified to 
identify the validity of interaction effects  
 
 M IE F  
Case 1 O ×  B 
Case 2 O O O BA 
Case 3 O O × B 
Case 4 × O O BA 
Case 5 × ×  B 
Case 6 × O × B 
 
As shown in this table, three cases were observed in the AI field which are related to the hypothesis 
1-a and 1-c. That is, it was found that there exists a positive (+) effect of the number of patents 
registered per employee on the ratio of sales increase per employee, profitability per employee, and 
the ratio of R&D expenditure to sales per employee with statistical significance.  Also, it is 
worthwhile to note that considering the main effects was enough in determining the effect of patent 
indices on business parameters without the inclusion of two-way interaction terms. It was observed 
that the involvement of two-way interaction terms made little difference albeit for increasing the 
complexity of the MLR analysis. As shown in Table 4-8 (AI case), the introduction of interaction 
effects gave only a slight improvement of the R-squared value from 0.988 to 0.9907.  
In the cases of Biotech, all six cases have generated results of statistical significance with the 
involvement of only the main effects. The results also showed the presence of a correlation of patent 
indices (except percentage of accepted patents) with business performance indicators in compliance 
with hypothesis 1-a. In addition, the results showed that one patent index (number of patents 
registered per employee) is negatively correlated with a number of business performance indicators 
(rate of sales increase, ratio of R&D expenditure to sales per employee) whereas those 
corresponding cases in AI showed positive correlations between them. As aforementioned, this 
negates hypothesis 1-b.  
As compared to the cases of AI and Biotech, for the Power plant field, there was only one case with 
statistical significance. This case showed that one patent index (patent registration ratio) has a 
５１ 
negative (-) effect on the business performance indicator, ratio of R&D to sales per employee. This is 
in compliance with hypothesis 1-a. In addition, the involvement of two-way interactions made no 
difference in the final outcome where the interaction effects produced no results of statistical 
significance.   
When all companies are considered, all six cases showed statistically significant results with the 
inclusion of only the main effects as given in Table 5-1. As aforementioned, when all companies are 
considered together, the prevailing effect of a field (or two fields) is sustained even after all 
companies are considered together, and the blending of the remaining dataset was not enough to 
overcome the effect carried over. 
The MLR results given in Tables 4-6, 4-12, and 4-19 indicate the existence of a positive correlation 
between the number of patents registered per employee and the profitability per employee for the 
corresponding cases in AI, Biotech and all companies, upholding hypothesis 1-d. In addition, by 
examining the MLR results of Tables 4-5, 4-10, and 4-17 along with Tables 4-8, 4-14, and 4-21, it is 
readily shown that the number of patents registered per employee is correlated with the rate of sales 
increase per employee as well the ratio of R&D expenditure to sales per employee. However, they 
don’t move in tandem; that is, the AI case showed a positive correlation in both situations while the 
rest demonstrated a negative correlation for the corresponding situation. This negates hypothesis 2-a. 
Table 5-2 Results of the Hypothesis tested 
Hypothesis   Variable     
Main Sub   Independent Dependent  Results Remarks 
H1 H1-a    Accepted  
 H1-b  Patent Business Rejected  
 H1-c  Indices Performance  Accepted AI 
 H1-d  (5 entries) Indicators Accepted AI, Bio, All 
H2 H2-a   (6 entries) Rejected    
 
Table 5-2 summarizes the validity of the hypotheses developed in Chapter III based upon the MLR 
５２ 
analysis discussed above without factor analysis on patent indices. 
3. Multiple Linear Regressions (MLR) with Factor Analysis 
It is worthwhile to note that, as in the corresponding cases without factor analysis, the response 
variables were again strongly affected by the main effects. This was also observed for the cases 
where all companies were considered together. Especially, in the AI cases, it was observed that there 
exists a close similarity between the corresponding cases in such a way that the response variables 
(business parameters) are correlated with the explanatory variables (patent indices) from the 
perspective of involving the main effects to produce results of statistical significance. In comparison, 
the Biotech cases showed no correlation results of statistical significance, which is totally different 
from those cases without factor analysis. It appears that the factored patent indices fail to carry 
sufficient information to be correlated with a business performance indicator by the MLR analysis as 
the factored patent indices are represented by a single number, called a “factor score.” 
More results are given in Appendix C. 
Table 5-3 Summary of MLR regression results (with factor analysis) 








Rate of sales increase  5 4 5 2 
Rate of sales increase per employee 3 4 5 2 
Profitability  5 4 5 4 
Profitability per employee 2 4 4 4 
Ratio of R&D expenditure to sales  5 4 5 2 
Ratio of R&D expenditure to sales per 





4. Limitations of the Research 
As the sample size is not very large (30 per industry), the results for one industry have a relatively 
strong influence on the regression results for the three industries combined (sample size of 90). That 
is, the association between a particular predictor variable and a response variable for one industry 
has an effect on the results for the sample comprising all three industries. 
The data used for this research consists of data from 2013 to 2017; the results may have been 
affected by the differences in technical cycle time (TCT) between industries.  
The most difficult part of this work was obtaining the relevant datasets. Especially, getting access to 
any materials or DB in this regard imposed a great difficulty as the bulk of information related to the 
business performance of firms were very limited. This acted as a kind of predicament in establishing 
a sound construct for the analysis of this work. Furthermore, the present analysis has extensively 
relied on p- and R-squared values in assessing the validity of the statistical outcome and it might be 
desirable to introduce additional means of investigation to consolidate whatever was found 
throughout this study, if applicable.  
There may have been some variables that should have been considered along with the patent indices 
in addition to those examined in this work to promote the research’s validity such as the TCT 
(technology cycle time), as well as some measure of the innovativeness of patented technologies, 
which could perhaps play somewhat important roles in conjunction with the patent indices applied in 
the MLR analysis. In addition, if possible, the merchantability of patented technology in terms of 
dollars and cents, as well as a quantifiable measure to assess the influence of time-lag in patent 
proceedings (in relation to business performance) are additional factors that could be considered 
along with the patent indices involved in the present work. The former will allow for a meaningful 
metric to assess the potential and cost-effectiveness of a patented technology. Meanwhile, the latter 
will provide some information concerning the appraisal of technologies under patent proceedings in 
conjunction with the TCT. Especially, this would allow for its inclusion in the present work, which 
was carried out using data from over a span of 5 years.  
５４ 
Furthermore, as witnessed in this work, the inclusion of two-way interaction terms made some 
difference in the final outcome of the statistical analysis, although those results seem to draw away 
from the original research model. This phenomenon might be implicating something in relation to 
the extra variables that could be accounted for in the analysis.     
If any of these were to be included in any way as part of the independent variables, the internal 
validity of the present work would have become enhanced by removing some potential confounding 
variables. 
The samples in this work were taken from companies with a higher number of patents than firms in 
general; therefore, this work’s external validity is compromised as it cannot be said that these results 
are applicable to firms with an average or lower amount of patent activity. 
As for construct validity, however, it can be said that the variables chosen in this work are reasonable 
measures for patent activity and business performance. In addition, if factors such as the 
applicability of patent technologies, technological similarity between patents, and potential 
spillovers could be put into measurable forms and included in the analysis, this would also have 
improved the validity of this work.  
Additionally, for future work, it may be conceivable to develop further improved hypotheses to 





The relationship between patent activities and business performance was investigated for three 
different fields of industry (AI, Biotech and Power plant). Linear as well as multiple linear 
regressions (MLR) were carried out to identify the significance of the correlation between various 
patent indices and measurable indicators (parameters) of business performance. Thirty companies 
were selected in each field for statistical examination, whose selection was based on the order of 
total number of patent applications filed during the period from 2013 to 2017 as found in USPTO 
(United States Patent and Trademark Office). Five patent indices were selected to measure patent 
activity and used as independent variables; patent application ratio, patent registration ratio, 
percentage of accepted patents, number of patent applications per employee and number of patent 
registrations per employee. Meanwhile, business performance was dealt with by using three 
categorical indices as dependent variables; the rate of sales increase (per employee), the profitability 
(per employee) and the ratio of R&D expenditure to sales. In addition, factor analysis was applied to 
the independent variables (patent activities) to identify and group whichever ones had a high 
correlation among themselves in conjunction with performing the MLR. 
Overall, the following could be concluded from the findings of the present research.  
First, it deems the results of the linear regressions can be used as reliable indicators to predict the 
outcome of the MLR regressions as one can envision the effect of an independent variable on a 
dependent variable. When examining the AI cases, the ones with low p-values (~0) also gave 
meaningful results in the MLR. That is, the ratio of sales increase per employee, profitability per 
employee, and the ratio of R&D expenditure to sales per employee showed a dependency on the 
number of patents registered per employee with statistical significance (p < 0.5), supporting 
hypotheses 1-a and 1-c. 
Second, the MLR regressions provided detailed statistical information on the relationship between 
each patent index and the business performance indicators all together, and, at the same time, to 
identify one factor’s relationship with the response variable as compared to the others. When only 
５６ 
the main effects were considered, three cases for the AI industry, six cases for the Biotech industry, 
and one case for the Power plant industry demonstrated the existence of a meaningful correlation 
between the patent activities and the responsive variables associated with business performance. 
When the interaction effects among patent indices were considered, many cases displayed an 
improvement in both p and R-squared values. Especially, in some cases, the introduction of two-way 
interaction terms consolidated the sound results already produced by considering only the main 
effects. This, however, tends to detract from the original research model in most cases and increase 
the complexity of the MLR analysis.  
 
Fig. 6-1 The effect of patent activity on business performance in different fields 
Third, the MLR results with factored predictor variables provided a means to measure the effect of 
two-way interaction terms from qualitative perspectives. For AI, the grouping of patent indices by 
factor analysis had little effect on the response variables associated with business performance. The 
inclusion of the main effects was enough in the MLR analysis. This was also sustained for the Power 
plant industry. The Biotech cases, however, showed a different picture as those cases of any 
statistical significance with the inclusion of interaction effects were not observed in the MLR 
analysis. This clearly manifests the significance of the interrelation between those predictor variables 
５７ 
included in different grouping variables, which is blocked by the grouping of predictor variables by 
factor analysis.  
Fourth, when all companies were considered together as one large sample, it appears that the 
prevailing effect of a predictor variable (patent index) on the response variable (measure of business 
performance) is reflected also in the results of linear regression as well as MLR analysis.  
This research provides useful referential information to any individual (entrepreneurs, practitioners, 
etc.) who aims to deduce whether an industry’s characteristics in relation to business performance 
would be similar to the AI, Biotech, or Power plant industries. This is very important as the patent 
strategy in link with business planning should be different from field to field and it is imperative to 
reflect the distinct features of the technologies associated with each field.  
Concerning technologies associated with AI, it might not be practical to proceed with the business 
until the stage where the technologies actually get registered and exclusive rights are legally 
obtained to release them into the market. Although both legal procedures of patent application and 
patent registration are important (as indicated by the results of this work), the former might be 
enough to function in the relevant market considering this field’s rather short technology cycle time 
(TCT). As a matter of fact, the timeline for patent registration tends to be longer than the TCT. 
Merely filing for patent applications might be an effective strategy which could both save time and 
expenses in performing any business activities associated with technologies that are worthwhile to 
protect but short-lived.  
In comparison, it is crucial to secure exclusive rights in the Biotech field as technologies in this 
industry are, more or less, directly involved with the development and production of new products to 
enter the market. In addition, as the TCT of Biotech is generally much longer than that of AI (>> 5 
years), it is practically important to exclude competitors from getting any benefits from exploiting 
similar technologies of any kind. This would preclude the possibility of a higher financial and 
technical market risk for a firm when it is in the stage of developing and releasing new products that 
are based off of new technologies.  
５８ 
In the field of heavy industry such as the Power plant industry, the patent strategy should be different 
from those of AI and Biotech and it might be practical to just file for patent applications for the 
purpose of warding off any imitation efforts by potential competitors (This action will block the 
efforts of competitors trying to secure the exclusive rights for a technology as it is very unlikely to 
be considered over the prior art.). This is not due to the TCT as was the case with AI. It may actually 
be a more realistic approach considering the characteristics of the Power plant industry, which 
generally deals with heavy and bulky machineries or equipment composed of millions of 
components involving a host of relevant technologies. Unless it deems really necessary to protect a 
technology by means of the patent system (as observed for Biotech), the strategic option of merely 
filing for patent application would be desirable for the sake of cost-effectiveness in the long run. In 
addition, many companies in this field tend to rely on the corporation’s knowhow (tacit knowledge), 
which has not been disclosed by patent applications, to a great degree.   
All in all, by exploring the results of this work, one would be able to get some idea about the 
industry and how the role of patents differs according to the business field, and such knowledge 
would help think up measures for dealing with technological planning and potential issues that could 
come up in a real world situation while doing business, especially as there is severe technical 
competition with high risks and uncertainty in many cases.  
５９ 
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Table B-1 Rate of sales increase (AI) 
Rate of sales increase (Case 5) 
Description 
Without Interaction 
Coefficients p-value S.E of Regression 
Patent Application Ratio -3.616041 0.143 2.387485 
Patent Registration Ratio 3.031792 0.183 2.20951 
Percentage of Accepted Patents -0.0343364 0.849 0.1778556 
Number of Patent Applications per Employee 1.02E+01 0.453 13.39769 
Number of Patents Registered per Employee -12.62963 0.494 18.19341 
_cons 0.0927411 0.217 0.0731377 
Number of Observations 30 
Sum squared resid 0.43527193 
R-Squared 0.1424 
Adjusted R-squared -0.0363 
Root MSE 0.13467 
p-value(F) 0.5626 
 
Table B-2 Rate of sales increase per employee (AI) 
Rate of sales increase per employee (Case 1) 
Description 
Without Interaction 
Coefficients p-value S.E of Regression 
Patent Application Ratio -0.0000351 0.853 0.0001873 
Patent Registration Ratio 0.000000834 0.996 0.0001734 
Percentage of Accepted Patents -0.00000893 0.528 0.000014 
Number of Patent Applications per Employee -9.18E-04 0.391 0.0010511 
Number of Patents Registered per Employee 0.0095397 0.000 0.0014274 
_cons 0.00000405 0.487 0.00000574 
Number of Observations 30 
Sum squared resid 2.6794E-09 
R-Squared 0.9745 
Adjusted R-squared 0.9691 
Root MSE 0.000011 
p-value(F) 0.0000 
７２ 
Table B-3 Profitability (AI) 
Profitability (Case 5) 
Description 
Without Interaction 
Coefficients p-value S.E of Regression 
Patent Application Ratio 0.9368107 0.85 4.895285 
Patent Registration Ratio -0.3746638 0.935 4.530368 
Percentage of Accepted Patents -0.138833 0.707 0.3646741 
Number of Patent Applications per Employee 3.07E+01 0.276 27.47054 
Number of Patents Registered per Employee -35.42862 0.352 37.30366 
_cons 0.3190563 0.044 0.149961 
Number of Observations 30 
Sum squared resid 1.82993419 
R-Squared 0.1413 
Adjusted R-squared -0.0376 
Root MSE 0.27613 
p-value(F) 0.5672 
 
Table B-4 Profitability per employee (AI) 
Profitability per employee (Case 1) 
Description 
Without Interaction 
Coefficients p-value S.E of Regression 
Patent Application Ratio 0.000288 0.405 0.0003398 
Patent Registration Ratio -0.0003725 0.248 0.0003145 
Percentage of Accepted Patents -0.00000979 0.702 0.0000253 
Number of Patent Applications per Employee -3.38E-03 0.089 0.0019069 
Number of Patents Registered per Employee 0.0352545 0.000 0.0025894 
_cons 0.00000654 0.536 0.0000104 
Number of Observations 30 
Sum squared resid 8.8174E-09 
R-Squared 0.9938 
Adjusted R-squared 0.9925 
Root MSE 0.000019 
p-value(F) 0.0000 
７３ 
Table B-5 Ratio of R&D expenditure to sale (AI) 
Ratio of R&D expenditure to sales (Case 5) 
Description 
Without Interaction 
Coefficients p-value S.E of Regression 
Patent Application Ratio 0.68334 0.578 1.21007 
Patent Registration Ratio -0.7187533 0.527 1.119865 
Percentage of Accepted Patents 0.0072436 0.937 0.0901441 
Number of Patent Applications per Employee 1.12E+01 0.113 6.790466 
Number of Patents Registered per Employee -15.12277 0.114 9.221124 
_cons 0.0913811 0.021 0.037069 
Number of Observations 30 
Sum squared resid 0.111815049 
R-Squared 0.1832 
Adjusted R-squared 0.0131 





Table B-6 Ratio of R&D expenditure to sales per employee (AI) 
Ratio of R&D expenditure to sales per employee (Case 2) 
Description 













Patent Application Ratio 0.000064 0.398 0.0000743 0.0000599 0.45 0.0000779 














Number of Patent Applications per 
Employee 
0.0004384 0.304 0.000417 0.0041929 0.005 0.0013524 
Number of Patents Registered per 
Employee 




ai1          
ai2          
ai3      0.0395098 0.007 0.0134042 




ai5         
ai6          
ai7          
ai8          
ai9          
ai10          
_cons -1.38E-07 0.952 0.00000228 -2.28E-07 0.911 0.00000203 
Number of Observations 30 30 
Sum squared resid 4.2169E-10 2.9966E-10 
R-Squared 0.9901 0.993 
Adjusted R-squared 0.988 0.9907 
Root MSE 0.0000042 0.0000037 
p-value(F) 0.0000 0.0000 
７５ 
 
Table B-7 Rate of sales increase (Biotech) 
Rate of sales increase (Case 3) 
Description 
Without Interaction 
Coefficients p-value S.E of Regression 
Patent Application Ratio -5.090797 0.035 2.273762 
Patent Registration Ratio 3.434153 0.047 1.642348 
Percentage of Accepted Patents -0.2846021 0.176 0.2039517 
Number of Patent Applications per Employee 5.18E+00 0.000 0.6159623 
Number of Patents Registered per Employee -6.765492 0.000 0.8572694 
_cons 0.2638593 0.037 0.1197856 
Number of Observations 30 
Sum squared resid 0.23269042 
R-Squared 0.7993 
Adjusted R-squared 0.7575 





Table B-8 Rate of sales increase per employee (Biotech) 
Rate of sales increase per employee (Case 2) 
Description 




















Patent Registration Ratio 0.0323652 0.218 0.0255726 0.0894717 0.039 0.0401758 







Number of Patent Applications per 
Employee 








0.000 0.0133483 1.155693 0.000 0.1928623 
ai1       
ai2    32.45923 0.002 9.127575 
ai3    -2.467339 0.000 0.3934796 
ai4    0.087573 0.000 0.0152937 
ai5       
ai6       
ai7    21.42666 0.005 6.756756 
ai8       
ai9    -42.66788 0.003 12.58363 
ai10    1.663532 0.000 0.3021723 
_cons 1.01E-03 0.593 0.0018651 1.22E-03 0.28 0.0010921 
Number of Observations 30 30 
Sum squared resid 5.64E-05 3.32E-06 
R-Squared 0.7089 0.9821 
Adjusted R-squared 0.6483 0.9712 
Root MSE 0.00153 0.00044 
p-value(F) 0.0000 0.0000 
  
７７ 
Table B-9 Profitability (Biotech) 
Profitability (Case 1) 
Description 
Without Interaction 
Coefficients p-value S.E of Regression 
Patent Application Ratio 5.605475 0.313 5.434165 
Patent Registration Ratio -3.845715 0.337 3.925119 
Percentage of Accepted Patents 0.6377124 0.203 0.4874332 
Number of Patent Applications per Employee -6.95E+00 0.000 1.472115 
Number of Patents Registered per Employee 8.921947 0.000 2.048826 
_cons -0.047425 0.87 0.2862809 
Number of Observations 30 
Sum squared resid 1.32908872 
R-Squared 0.5779 
Adjusted R-squared 0.49 





Table B-10 Profitability per employee (Biotech) 
Profitability per employee (Case 2) 
Description 













Patent Application Ratio 0.0669617 0.266 0.0588474 0.0978418 0.175 0.0693263 







Percentage of Accepted Patents 0.0034893 0.515 0.0052785 0.0037812 0.292 0.00348 




0.000 0.0159418 1.157497 0.000 0.2500103 
Number of Patents Registered per 
Employee 
0.1236194 0.000 0.0221871 -1.812532 0.000 0.33484 
ai1          
ai2     -48.89574 0.006 15.84694 
ai3     3.814101 0.000 0.6831438 
ai4     
-
0.1581381 0.000 0.0265524 
ai5          
ai6          
ai7     -32.17791 0.013 11.73082 
ai8          
ai9     64.15963 0.009 21.8472 
ai10     -2.487012 0.000 0.5246198 
_cons -1.78E-03 0.572 0.0031002 -1.67E-03 0.391 0.0018961 
Number of Observations 30 30 
Sum squared resid 1.56E-04 1.04E-05 
R-Squared 0.6305 0.9752 
Adjusted R-squared 0.5535 0.9601 
Root MSE 0.00255 0.00076 




Table B-11 Ratio of R&D expenditure to sales (Biotech) 
Ratio of R&D expenditure to sales (Case 3) 
Description 
Without Interaction 
Coefficients p-value S.E of Regression 
Patent Application Ratio -6.335762 0.123 3.966079 
Patent Registration Ratio 4.339237 0.143 2.864715 
Percentage of Accepted Patents -0.2731155 0.45 0.355749 
Number of Patent Applications per Employee 8.35E+00 0.000 1.074411 
Number of Patents Registered per Employee -10.51592 0.000 1.495318 
_cons 0.3593922 0.098 0.2089397 
Number of Observations 30 
Sum squared resid 0.707964003 
R-Squared 0.7887 
Adjusted R-squared 0.7447 





Table B-12 Ratio of R&D expenditure to sales per employee (Biotech) 
Ratio of R&D expenditure to sales per employee (Case 2) 
Description 













Patent Application Ratio 
-
0.0987486 
0.238 0.0816522 0.1175787 0.075 0.0624035 




Percentage of Accepted Patents 
-
0.0046333 
0.533 0.007324 0.0019911 0.7 0.0050898 
Number of Patent Applications per 
Employee 
0.1413128 0.000 0.0221196 -0.787919 0.01 0.2739608 




0.000 0.0307851 1.738835 0.002 0.4837998 
ai1          
ai2           
ai3     -3.406897 0.001 0.8865906 
ai4     0.209826 0.000 0.0445119 
ai5          
ai6          
ai7     -5.883163 0.000 0.7886241 
ai8          
ai9     4.676737 0.000 0.8186225 
ai10     1.638375 0.004 0.4972943 
_cons 2.44E-03 0.576 0.0043016 -2.06E-03 0.45 0.0026678 
Number of Observations 30 30 
Sum squared resid 3.00E-04 3.11E-05 
R-Squared 0.7061 0.9696 
Adjusted R-squared 0.6449 0.9536 
Root MSE 0.00354 0.00128 




Table B-13 Rate of sales increase (Power plant) 
Rate of sales increase (Case 5) 
Description 
Without Interaction 
Coefficients p-value S.E of Regression 
Patent Application Ratio -0.5662579 0.446 0.7304462 
Patent Registration Ratio 0.4285753 0.628 0.8725179 
Percentage of Accepted Patents 0.045955 0.668 0.1058273 
Number of Patent Applications per Employee 2.53E+01 0.223 20.20437 
Number of Patents Registered per Employee -42.13329 0.204 32.2951 
_cons 0.0070133 0.928 0.0766873 
Number of Observations 30 
Sum squared resid 0.072289771 
R-Squared 0.086 
Adjusted R-squared -0.1044 
Root MSE 0.05488 
p-value(F) 0.8079 
 
Table B-14 Rate of sales increase per employee (Power plant) 
Rate of sales increase per employee (Case 5) 
Description 
Without Interaction 
Coefficients p-value S.E of Regression 
Patent Application Ratio -0.0000297 0.127 0.0000188 
Patent Registration Ratio 0.0000225 0.327 0.0000225 
Percentage of Accepted Patents 0.00000196 0.48 0.00000272 
Number of Patent Applications per Employee 1.32E-03 0.018 0.00052 
Number of Patents Registered per Employee -0.0019965 0.024 0.0008312 
_cons -0.00000074 0.711 0.00000197 
Number of Observations 30 
Sum squared resid 4.7886E-11 
R-Squared 0.2625 
Adjusted R-squared 0.1088 
Root MSE 0.0000014 
p-value(F) 0.1711 
８２ 
Table B-15 Profitability (Power plant) 
Profitability (Case 6 ) 
Description 
Without Interaction 
Coefficients p-value S.E of Regression 
Patent Application Ratio 0.6294259 0.439 0.7993896 
Patent Registration Ratio -0.6053804 0.532 0.9548709 
Percentage of Accepted Patents -0.1144465 0.333 0.1158158 
Number of Patent Applications per Employee -2.67E+01 0.239 22.11137 
Number of Patents Registered per Employee 51.25643 0.16 35.34329 
_cons 0.1312107 0.131 0.0839254 
Number of Observations 30 
Sum squared resid 0.086579969 
R-Squared 0.144 
Adjusted R-squared -0.0343 
Root MSE 0.06006 
p-value(F) 0.5557 
 
Table B-16 Profitability per employee (Power plant) 
Profitability per employee (Case 6 ) 
Description 
Without Interaction 
Coefficients p-value S.E of Regression 
Patent Application Ratio 0.0000903 0.136 0.0000585 
Patent Registration Ratio -0.0001389 0.058 0.0000699 
Percentage of Accepted Patents 2.34E-08 0.998 0.00000847 
Number of Patent Applications per Employee -2.10E-03 0.207 0.0016177 
Number of Patents Registered per Employee 0.0048033 0.076 0.0025858 
_cons 0.00000123 0.843 0.00000614 
Number of Observations 30 
Sum squared resid 4.6345E-10 
R-Squared 0.2845 
Adjusted R-squared 0.1354 
Root MSE 0.0000044 
p-value(F) 0.1303 
８３ 
Table B-17 Ratio of R&D expenditure to sales (Power plant) 
Ratio of R&D expenditure to sales (Case 5) 
Description 
Without Interaction 
Coefficients p-value S.E of Regression 
Patent Application Ratio -0.2279049 0.49 0.3247906 
Patent Registration Ratio 0.2506228 0.524 0.3879624 
Percentage of Accepted Patents -0.0065866 0.89 0.0470558 
Number of Patent Applications per Employee 3.23E+00 0.722 8.98381 
Number of Patents Registered per Employee -6.069245 0.676 14.35992 
_cons 0.0507699 0.15 0.0340988 
Number of Observations 30 
Sum squared resid 0.014292473 
R-Squared 0.0219 
Adjusted R-squared -0.1818 
Root MSE 0.0244 
p-value(F) 0.9896 
 
Table B-18 Ratio of R&D expenditure to sales per employee (Power plant) 
Ratio of R&D expenditure to sales per employee  (Case 3) 
Description 
Without Interaction 
Coefficients p-value S.E of Regression 
Patent Application Ratio 0.0000175 0.184 0.0000128 
Patent Registration Ratio -0.0000361 0.027 0.0000153 
Percentage of Accepted Patents 0.000000686 0.714 0.00000185 
Number of Patent Applications per Employee -2.15E-04 0.55 0.0003538 
Number of Patents Registered per Employee 0.0008542 0.144 0.0005656 
_cons 0.000000322 0.813 0.00000134 
Number of Observations 30 
Sum squared resid 2.217E-11 
R-Squared 0.4562 
Adjusted R-squared 0.3429 
Root MSE 0.00000096 
p-value(F) 0.0085 
８４ 
Table B-19 Rate of sales increase (All companies) 
Rate of sales increase  (Case 1) 
Description 
Without Interaction 
Coefficients p-value S.E of Regression 
Patent Application Ratio -2.62041 0.064 1.394163 
Patent Registration Ratio 1.463218 0.21 1.159082 
Percentage of Accepted Patents -0.0409492 0.461 0.0552303 
Number of Patent Applications per Employee 5.46E+00 0.000 0.5938859 
Number of Patents Registered per Employee -7.135073 0.000 0.8286443 
_cons 0.0866389 0.008 0.032013 
Number of Observations 90 
Sum squared resid 0.85594788 
R-Squared 0.5523 
Adjusted R-squared 0.5257 





Table B-20 Rate of sales increase per employee (All companies) 
Rate of sales increase per employee (Case 2) 
Description 




















Patent Registration Ratio 0.0106297 0.284 0.0098517 0.169228 0.003 0.0544145 




Number of Patent Applications per 
Employee 








0.000 0.0070431 0.3879916 0.000 0.0864373 
ai1          
ai2     44.40794 0.000 7.362062 




ai4     0.0287027 0.000 0.0060268 
ai5          
ai6          
ai7     29.46768 0.000 5.827738 




ai9     -56.28602 0.000 9.905648 
ai10     0.7051472 0.000 0.1339076 
_cons -1.95E-04 0.477 0.0002721 1.78E-04 0.235 0.0001485 
Number of Observations 90 90 
Sum squared resid 6.18E-05 1.03E-05 
R-Squared 0.6929 0.9488 
Adjusted R-squared 0.6746 0.9409 
Root MSE 0.00086 0.00037 
p-value(F) 0.0000 0.0000 
  
８６ 
Table B-21 Profitability (All companies) 
Profitability  (Case 3) 
Description 
Without Interaction 
Coefficients p-value S.E of Regression 
Patent Application Ratio -0.4162806 0.896 3.175517 
Patent Registration Ratio 1.971701 0.457 2.640068 
Percentage of Accepted Patents -0.4233329 0.001 0.1257994 
Number of Patent Applications per Employee -6.84E+00 0.000 1.352708 
Number of Patents Registered per Employee 9.183826 0.000 1.887423 
_cons 0.4454232 0 0.0729169 
Number of Observations 90 
Sum squared resid 4.44067848 
R-Squared 0.3171 
Adjusted R-squared 0.2765 













Table B-22 Profitability per employee (All companies) 
Profitability per employee (Case 2) 
Description 













Patent Application Ratio 0.0193262 0.327 0.0196185 0.1464946 0.002 0.0456633 







Percentage of Accepted Patents 
-
0.0000865 
0.912 0.0007772 0.0005542 0.194 0.0004232 




0.000 0.0083571 0.4265503 0.000 0.1027182 
Number of Patents Registered per 
Employee 




ai1          
ai2     -66.26188 0.000 11.7834 
ai3     1.636311 0.000 0.2850143 




ai5          
ai6          
ai7     -43.75152 0.000 9.327629 
ai8     0.1601397 0.031 0.0727796 
ai9     83.66548 0.000 15.85456 
ai10     -1.070316 0.000 0.2143267 
_cons 2.62E-04 0.562 0.0004505 -2.75E-04 0.252 0.0002376 
Number of Observations 90 90 
Sum squared resid 1.69E-04 2.64E-05 
R-Squared 0.6084 0.939 
Adjusted R-squared 0.5851 0.9295 
Root MSE 0.00142 0.00059 




Table B-23 Ratio of R&D expenditure to sales (All companies) 
Ratio of R&D expenditure to sales (Case 2) 
Description 













Patent Application Ratio -2.46844 0.112 1.539055 -1.694085 0.273 1.533796 
Patent Registration Ratio 2.037679 0.115 1.279542 1.017317 0.442 1.318276 




Number of Patent Applications per 
Employee 
9.048471 0.000 0.6556069 7.728671 0.000 0.847471 
Number of Patents Registered per 
Employee 
-11.33257 0.000 0.9147633 -8.018474 0.000 1.659086 
ai1          
ai2       
 
  
ai3       
 
  
ai4     -1.456803 0.02 0.6152953 
ai5          
ai6          
ai7       
 
  
ai8       
 
  
ai9       
 
  
ai10       
 
  
_cons 1.50E-01 0 0.0353401 1.46E-01 0 0.0344542 
Number of Observations 90 90 
Sum squared resid 1.04E+00 9.77E-01 
R-Squared 0.7678 0.7825 
Adjusted R-squared 0.7539 0.7667 
Root MSE 0.11144 0.1085 





Table B-24 Ratio of R&D expenditure to sales per employee (All companies) 
Ratio of R&D expenditure to sales per employee (Case 2) 
Description 




















Patent Registration Ratio 0.0211138 0.354 0.0226753 0.3948232 0.002 0.1208832 
Percentage of Accepted Patents 0.0003064 0.777 0.0010805 -0.000822 0.166 0.0005873 
Number of Patent Applications per 
Employee 








0.000 0.0162109 0.8697075 0.000 0.1920226 
ai1          
ai2     99.42748 0.000 16.35499 
ai3     -2.190855 0.000 0.3955909 
ai4     0.0780281 0.000 0.0133886 
ai5          
ai6          
ai7     65.69161 0.000 12.94645 
ai8     
-
0.2607383 0.012 0.1010158 
ai9     -125.8089 0.000 22.00563 
ai10     1.544603 0.000 0.2974787 
_cons -4.28E-04 0.496 0.0006263 3.97E-04 0.232 0.0003298 
Number of Observations 90 90 
Sum squared resid 3.28E-04 5.08E-05 
R-Squared 0.6924 0.9523 
Adjusted R-squared 0.6741 0.9448 
Root MSE 0.00197 0.00081 












C. Multilinear Regression Results 





Table C-1 Rate of sales increase per employee (AI) 
Rate of sales increase per employee (Case 3) 
Description 
Without Interaction 
Coefficients p-value S.E of Regression 
AIP1 -0.00000424 0.076 0.0000023 
AIP2 0.0000588 0.000 0.00000232 
AIP3 0.00000864 0.001 0.00000232 
_cons 1.41E-05 0 0.00000226 
Number of Observations 30 
Sum squared resid 3.9751E-09 
R-Squared 0.9621 
Adjusted R-squared 0.9577 
Root MSE 0.000012 
p-value(F) 0.0000 
 
Table C-2 Profitability per employee (AI) 
Profitability per employee (Case 2) 
Description 
Without Interaction With Interaction 
Coefficients p-value S.E of Regression Coefficients p-value S.E of Regression 
AIP1 -0.0000147 0.022 0.000006 -9.10E-06 0.012 3.34E-06 
AIP2 0.0002187 0.000 0.00000606 0.0001691 0.000 7.49E-06 
AIP3 0.0000292 0.000 0.00000607 0.0000297 0.000 4.41E-06 
ai1           
ai2      0.0000684 0.000 9.59E-06 
ai3      -0.0000177 0.025 7.44E-06 
_cons 5.35E-05 0 5.90E-06 0.0000533 0 3.19E-06 
Number of Observations 30 30 
Sum squared resid 2.7173E-08 7.34E-09 
R-Squared 0.9808 0.9948 
Adjusted R-squared 0.9786 0.9938 
Root MSE 0.000032 1.70E-05 






Table C-3 Rate of R&D expenditure to sales per employee (AI) 
Ratio of R&D expenditure to sales per employee (Case 2) 
Description 







AIP1 -0.00000282 0.004 0.000000908 -2.37E-06 0.005 7.64E-07 
AIP2 0.000038 0.000 0.000000916 0.0000325 0.000 1.73E-06 
AIP3 0.00000429 0.000 0.000000918 0.00000362 0.000 7.85E-07 
ai1           
ai2      0.00000781 0.001 2.19E-06 
ai3        
 
  
_cons 1.09E-05 0 8.92E-07 0.0000108 0 7.41E-07 
Number of Observations 30 30 
Sum squared resid 6.21E-10 4.11E-10 
R-Squared 0.9854 0.9903 
Adjusted R-squared 0.9837 0.9888 
Root MSE 0.0000049 4.10E-06 
p-value(F) 0.0000 0.0000 
 
Table C-4 Rate of sales increase (Biotech) 
Rate of sales increase (Case 4) 
Description 




Coefficients p-value S.E of Regression 
BTP1 -0.0457607 0.222 0.036568 -2.33E-01 0.008 8.04E-02 
BTP2 0.0560512 0.139 0.0367512 0.2220999 0.000 5.45E-02 
BTP3 -0.0035411 0.924 0.0368226 -0.2096912 0.002 5.86E-02 
ai1           
ai2      -0.6275612 0.001 0.1677102 
ai3      0.1612382 0.007 0.054851 
_cons 1.36E-01 0.001 0.0359501 0.13786 0 2.78E-02 
Number of Observations 30 30 
Sum squared resid 1.01E+00 5.58E-01 
R-Squared 0.1305 0.5186 
Adjusted R-squared 0.0302 0.4183 
Root MSE 0.19691 1.52E-01 




Table C-5 Ratio of R&D expenditure to sales per employee (Power plant) 






PPP1 -4.39E-07 0.025 0.000000184 
PPP2 0.000000587 0.004 0.000000186 
PPP3 2.86E-09 0.988 0.000000193 
_cons 1.02E-06 0 0.000000181 
Number of Observations 30 
Sum squared resid 2.5502E-11 
R-Squared 0.3744 
Adjusted R-squared 0.3022 
Root MSE 0.00000099 
p-value(F) 0.0061 
 
Table C-6 Rate of sales increase (All companies) 
Rate of sales increase (Case 2) 
Description 
Without Interaction Without Interaction 
Coefficients p-value S.E of Regression Coefficients p-value S.E of Regression 
P1 -0.024531 0.102 0.0148598 3.14E-02 0.08 1.77E-02 
P2 0.0432362 0.005 0.0149337 0.0487257 0.000 1.34E-02 
P3 -0.0064331 0.67 0.0150378 0.0009656 0.943 1.35E-02 
ai1        
 
  
ai2      -0.2760183 0.000 0.0578524 
ai3        
 
  
_cons 8.13E-02 0 0.0147768 0.0816007 0 1.32E-02 
Number of Observations 90 90 
Sum squared resid 1.69E+00 1.33E+00 
R-Squared 0.116 0.3028 
Adjusted R-squared 0.0852 0.2699 
Root MSE 0.14018 1.25E-01 
p-value(F) 0.0137 0.0000 
  
９４ 
Table C-7 Rate of sales increase per employee (All companies) 
Rate of sales increase per employee (Case 2) 
Description 
Without Interaction Without Interaction 
Coefficients p-value S.E of Regression Coefficients p-value S.E of Regression 
P1 -0.0000924 0.541 0.0001507 5.26E-04 0.000 1.25E-04 
P2 0.0005408 0.001 0.0001514 0.0005798 0.000 9.00E-05 
P3 -0.0001088 0.477 0.0001525 -0.0011468 0.000 2.05E-04 
ai1        
 
  
ai2      -0.0050438 0.000 0.0004047 
ai3      0.0003069 0.000 0.000049 
_cons 2.10E-04 0.164 0.0001498 0.0002158 0.017 8.84E-05 
Number of Observations 90 90 
Sum squared resid 1.74E-04 5.91E-05 
R-Squared 0.1368 0.7066 
Adjusted R-squared 0.1067 0.6891 
Root MSE 0.00142 8.40E-04 
p-value(F) 0.0053 0.0000 
 
Table C-8 Ratio of R&D expenditure to sales (All companies) 
Ratio of R&D expenditure to sales (Case 2) 
Description 
Without Interaction Without Interaction 
Coefficients p-value S.E of Regression Coefficients p-value S.E of Regression 
P1 -0.0154037 0.457 0.0206009 3.24E-02 0.131 2.12E-02 
P2 0.1156375 0.000 0.0207035 0.1169253 0.000 1.52E-02 
P3 -0.0226066 0.281 0.0208478 -0.1915523 0.000 3.48E-02 
ai1        
 
  
ai2      -0.5475956 0.000 0.0685249 
ai3      0.0480316 0.000 0.0082999 
_cons 1.48E-01 0 2.05E-02 0.1486804 0 1.50E-02 
Number of Observations 90 90 
Sum squared resid 3.25E+00 1.69E+00 
R-Squared 0.2768 0.6228 
Adjusted R-squared 0.2516 0.6004 
Root MSE 0.19435 1.42E-01 
p-value(F) 0.0000 0.0000 
 
９５ 
Table C-9 Ratio of R&D expenditure to sales per employee (All companies) 
Ratio of R&D expenditure to sales per employee(Case 2) 
Description 
Without Interaction Without Interaction 
Coefficients p-value S.E of Regression Coefficients p-value S.E of Regression 
P1 -0.000215 0.518 0.0003312 1.13E-03 0.000 2.84E-04 
P2 0.0015674 0.000 0.0003328 0.0016531 0.000 2.03E-04 
P3 -0.0002439 0.469 0.0003351 -0.0024685 0.000 4.64E-04 
ai1           
ai2      -0.0109299 0.000 0.0009148 
ai3      0.0006585 0.000 0.0001108 
_cons 5.00E-04 0.132 3.29E-04 0.0005128 0.012 2.00E-04 
Number of Observations 90 90 
Sum squared resid 8.39E-04 3.02E-04 
R-Squared 0.2119 0.7165 
Adjusted R-squared 0.1844 0.6996 
Root MSE 0.00312 1.90E-03 
p-value(F) 0.0001 0.0000 
 
  
